2012
DOI: 10.1016/j.actatropica.2011.09.009
|View full text |Cite
|
Sign up to set email alerts
|

Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 37 publications
0
13
0
Order By: Relevance
“…This observation was also made among children under 5 years of age in the study area [18] and may stem from recurring parasitaemia following treatment. Drug resistance markers associated with reappearing parasitaemia following artemether-lumefantrine treatment are established in the study area [33, 34], but reports on actual treatment failure are absent. No information on the completeness of treatment was collected, i.e., on adherence to the 3-days regimen, but incomplete drug intake, e.g., in the community or after the first dose in a health facility, may have contributed to reappearing parasitaemia.…”
Section: Discussionmentioning
confidence: 99%
“…This observation was also made among children under 5 years of age in the study area [18] and may stem from recurring parasitaemia following treatment. Drug resistance markers associated with reappearing parasitaemia following artemether-lumefantrine treatment are established in the study area [33, 34], but reports on actual treatment failure are absent. No information on the completeness of treatment was collected, i.e., on adherence to the 3-days regimen, but incomplete drug intake, e.g., in the community or after the first dose in a health facility, may have contributed to reappearing parasitaemia.…”
Section: Discussionmentioning
confidence: 99%
“…In Kabale and Rukungiri, Uganda, samples from 2005 showed a high prevalence of the A581G mutation at 45% and 46%, respectively ( 27 ); studies during 2005–2006 in Rukara and Mahesha, Rwanda, observed prevalences of 60% and 29%, respectively ( 28 ). A study in 2010 in Huye District, Southern Province, Rwanda, reported a prevalence of 63% ( 35 ). In eastern Sudan, a study found an increase in the prevalence of the A581G mutation from 14% in 2003 to 34% in 2012 ( 36 ).…”
Section: Discussionmentioning
confidence: 99%
“…Overall, the present study reported a progressive mutation in dhfr and dhps of P. falciparum isolates in the interior division of Sabah, where triple mutations are now prevalent in both genes compared to the previous study with double mutations on both genes. A sextuple allele combination of pfdhfr-pfdhps is associated with high-grade clinical resistance to SDX/PYR, which was found mainly in Africa [22,23]. The other three alleles found in Sabah range from triple mutation to quintuple mutations (ANRNI-SGKAA, AIRNI-AAKAA, ANRNL-SGKGA), which could modulate varying degree of resistance to SDX/PYR therapy.…”
Section: Discussionmentioning
confidence: 99%